Literature DB >> 14735774

National survey of quality assurance activities for pharmacy-compounded sterile preparations.

Aisha M Morris1, Philip J Schneider, Craig A Pedersen, Jay M Mirtallo.   

Abstract

The compliance of hospitals' quality assurance practices for pharmacy-compounded sterile preparations with the American Society of Health-System Pharmacists (ASHP) Guidelines on Quality Assurance for Pharmacy-Prepared Sterile Products was studied. A survey based on the 2000 ASHP guidelines was developed to determine current practices for compounding sterile preparations in hospital pharmacies. Practices were compared with those identified in a 1995 ASHP survey. The survey was mailed in July 2002 to a stratified random sample of 600 hospital pharmacy directors. There were a total of 182 usable responses, for a net response rate of 30.3%. Quality assurance practices for some quality domains showed low compliance with the 2000 ASHP guidelines. Only 5.2% of pharmacies that compounded risk level 1 preparations were compliant with garb requirements. Only 4.7% of pharmacies compounding risk level 3 preparations were compliant with recommendations for documentation. Compliance with guidelines on the use of resources to determine expiration dates was high (95.5%). Hospitals were moderately compliant with guidelines related to personnel training (62.7%) and labeling (61.1%). Although some improvements were observed, hospital pharmacies in 2002 were still not fully compliant with the ASHP Guidelines on Quality Assurance for Pharmacy-Prepared Sterile Products.

Mesh:

Year:  2003        PMID: 14735774     DOI: 10.1093/ajhp/60.24.2567

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  6 in total

1.  Survey of sterile admixture practices in canadian hospital pharmacies: part 2. More results and discussion.

Authors:  Travis Warner; Cesilia Nishi; Ryan Checkowski; Kevin W Hall
Journal:  Can J Hosp Pharm       Date:  2009-05

2.  Survey of sterile admixture practices in canadian hospital pharmacies: part 1. Methods and results.

Authors:  Travis Warner; Cesilia Nishi; Ryan Checkowski; Kevin W Hall
Journal:  Can J Hosp Pharm       Date:  2009-03

3.  Assessment of implementation of a standardized parenteral formulation for early nutritional support of very preterm infants.

Authors:  Richard Lenclen; Sylvie Crauste-Manciet; Philippe Narcy; Saida Boukhouna; Amélie Geffray; Marie-Noëlle Guerrault; François Bordet; Denis Brossard
Journal:  Eur J Pediatr       Date:  2006-04-19       Impact factor: 3.183

Review 4.  Straight from the headlines: what is going on in compounding pharmacies, and how can clinical microbiologists help?

Authors:  Alice S Weissfeld
Journal:  J Clin Microbiol       Date:  2013-06-19       Impact factor: 5.948

5.  Pseudomonas putida septicemia in a special care nursery due to contaminated flush solutions prepared in a hospital pharmacy.

Authors:  Joseph F Perz; Allen S Craig; Charles W Stratton; Stanley J Bodner; Walter E Phillips; William Schaffner
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

6.  Sphingomonas paucimobilis bloodstream infections associated with contaminated intravenous fentanyl.

Authors:  Lisa L Maragakis; Romanee Chaiwarith; Arjun Srinivasan; Francesca J Torriani; Edina Avdic; Andrew Lee; Tracy R Ross; Karen C Carroll; Trish M Perl
Journal:  Emerg Infect Dis       Date:  2009-01       Impact factor: 6.883

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.